MedPath

TARO-POSACONAZOLE

TARO-POSACONAZOLE

Approved
DIN Number

02543311

Drug Class

Human

Market Date

Mar 25, 2024

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02543311
AIG Number0152201002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC04 POSACONAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
Health Canada Classification

ACTIVE INGREDIENTS (1)

POSACONAZOLEActive
Strength: 100 MG
Monograph: POSACONAZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.